Saturday, March 25, 2006

AstraZeneca's CRESTOR Reduces LDL-C Or "bad" Cholesterol - Quick Facts

"AstraZeneca said that its CRESTOR reduced LDL-C or "bad" cholesterol by 45.2 and 50.0 % compared to 35.9 and 42.4% with atorvastatin at milligram-equivalent doses in Hispanic patients with elevated cholesterol."

Daytrading Eminis Forex trading Swing Trading BREAKING NEWS - 202940

0 Comments:

Post a Comment

<< Home